Every SEC Form 3/4/5 on record for this filer (CIK 1324015) — 4 issuers, 64 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Director | 2015-08-07 → 2026-05-07 | 20 | −$3M |
| QCOM | QUALCOMM INC/DE | Director | 2016-01-14 → 2026-03-18 | 23 | −$1M |
| BDX | BECTON DICKINSON & CO | Director | 2018-08-16 → 2026-01-29 | 10 | $350,430 |
| FGEN | FIBROGEN INC | Director · lapsed | 2015-08-13 → 2023-09-06 | 13 | −$133,445 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| HALO | 2025-04-28 | Sell | 200 | $61.00 | $12,200 | 28,611 |
| HALO | 2025-04-28 | Sell | 4,297 | $60.34 | $259,281 | 28,811 |
| HALO | 2025-04-01 | Sell | 503 | $64.05 | $32,217 | 33,108 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.